Rita, Luís
Neumann, Natalie R.
Laponogov, Ivan
Gonzalez, Guadalupe
Veselkov, Dennis
Pratico, Domenico
Aalizadeh, Reza
Thomaidis, Nikolaos S.
Thompson, David C.
Vasiliou, Vasilis
Veselkov, Kirill
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (2021.05460.BD)
ERC Proof of Concept (899932 (Hyperfoods), 899932 (Hyperfoods), 899932 (Hyperfoods), 899932 (Hyperfoods), 899932 (Hyperfoods))
UK Research and Innovation (10058099, 10058099, 10058099, 10058099, 10058099)
European Union (101095359, 101095359, 101095359, 101095359, 101095359)
Vodafone Foundation (CORONA-AI/DRUGS DreamLab, CORONA-AI/DRUGS DreamLab, CORONA-AI/DRUGS DreamLab, CORONA-AI/DRUGS DreamLab, CORONA-AI/DRUGS DreamLab)
NIHR Imperial Biomedical Research Centre
ERC-Consolidator (724228 (LEMAN), 724228 (LEMAN), 724228 (LEMAN))
Article History
Received: 19 May 2023
Accepted: 20 June 2023
First Online: 7 July 2023
Declarations
:
: Drs Vasiliou, Veselkov, and Thomaidis are serving as Editors for the Journal of Human Genomics and will exclude themselves from the review process.
: The authors declare no competing interests.